Mammography Imbroglio Makes Case For More Stakeholder Input In CER – AHRQ’s Clancy (The Pink Sheet)
This is copyright protected information, to receive the full article, please click here to sign up and register.
Senate Considers Revised Comparative Effectiveness Plan In Reform Bill (The Pink Sheet)
This is copyright protected information, to receive the full article, please click here to sign up and register.
FDA Panel To Consider Label Changes For GE, Bayer MRI Drugs (Dow Jones)
Caleco Pharma Corp. Announces Negotiations to Form a Strategic Alliance With Rearden Health Partners (Marketwire)
New Report Recommends Banning Gifts Between Doctors and Drug Companies (Cape May County Herald)
Pediapharm Launches EpiCeram(R) (Marketwire)
Bristol-Myers Squibb, Pfizer to Seek European Approval for apixaban in H1 ‘10 (PharmaLive)
New ad campaign pushes swine flu vaccinations (CBS News)
Further delay to Bayer, J&J’s response to FDA over Xarelto (PharmaTimes)
Jenkins Suggests “Complete Response” Letter Transparency Could Prompt Better Drug Applications, Faster Reviews (The Pink Sheet)
This is copyright protected information, to receive the full article, please click here to sign up and register.
A Rare Opportunity? FDA Orphan Products Head Makes The Case For More Big Pharma Investment In Rare Diseases (The Pink Sheet)
This is copyright protected information, to receive the full article, please click here to sign up and register.
SUBSCRIBE